119th Congress · introduced in the Senate · Jan 30, 2025
HALT Fentanyl Act
Official title from Congress.gov
Latest action (Jul 16, 2025): Became Public Law No: 119-26.
View on Congress.govPolicy area: Crime and Law Enforcement
Congressional Research Service summary, version: Public Law (Jul 17, 2025) · 2 versions published
Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act
This act permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.
Under the act, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term).
Additionally, the act establishes a new, alternative registration process for certain schedule I research.
The act also makes several other changes to registration requirements for conducting research with controlled substances, including
• permitting a single registration for related research sites in certain circumstances,
• waiving the requirement for a new inspection in certain situations, and
• allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.
Finally, the act expresses the sense that Congress agrees with the interpretation of the Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.
Show less of the summaryIncludes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
House · Jun 12, 2025 · Roll call 166 · Passed
Senate · Mar 14, 2025 · Roll call 127 · Bill Passed
Senate · Mar 13, 2025 · Roll call 124 · Cloture Motion Agreed to
Senate · Mar 6, 2025 · Roll call 110 · Cloture on the Motion to Proceed Agreed to
Became Public Law No: 119-26.
Became Public Law No: 119-26.
Signed by President.
Signed by President.
Presented to President.
Presented to President.
Motion to reconsider laid on the table Agreed to without objection.
On passage Passed by the Yeas and Nays: 321 - 104 (Roll no. 166). (text: 6/11/2025 CR H2625-2627) Roll call details
Passed/agreed to in House: On passage Passed by the Yeas and Nays: 321 - 104 (Roll no. 166). (text: 6/11/2025 CR H2625-2627) Roll call details
Considered as unfinished business. (consideration: CR H2806)
POSTPONED PROCEEDINGS - At the conclusion of debate on S. 331, the Chair put the question on passage of the bill and by voice vote, announced that the ayes had prevailed. Mr. Pallone demanded the yeas and nays and the Chair postponed further proceedings until a time to be announced.
The previous question was ordered pursuant to the rule.
DEBATE - The House proceeded with one hour of debate on S. 331.
Rule provides for consideration of H.R. 884, H.R. 2056, H.R. 2096 and S. 331. The resolution provides for consideration of H.R. 884, H.R. 2056, H.R. 2096, and S. 331 under a closed rule with one hour of general debate for each bill. The resolution provides for one motion to recommit on H.R. 884, H.R. 2056, and H.R. 2096, and one motion to commit on S. 331.
Considered under the provisions of rule H. Res. 489. (consideration: CR H2625-2633)
Rule H. Res. 489 passed House.
Rules Committee Resolution H. Res. 489 Reported to House. Rule provides for consideration of H.R. 884, H.R. 2056, H.R. 2096 and S. 331. The resolution provides for consideration of H.R. 884, H.R. 2056, H.R. 2096, and S. 331 under a closed rule with one hour of general debate for each bill. The resolution provides for one motion to recommit on H.R. 884, H.R. 2056, and H.R. 2096, and one motion to commit on S. 331.
Held at the desk.
Received in the House.
Message on Senate action sent to the House.
Passed Senate with an amendment by Yea-Nay Vote. 84 - 16. Record Vote Number: 127. Roll call details
Passed/agreed to in Senate: Passed Senate with an amendment by Yea-Nay Vote. 84 - 16. Record Vote Number: 127. Roll call details
The committee substitute agreed to by Unanimous Consent.
Considered by Senate. (consideration: CR S1762-1765)
Considered by Senate. (consideration: CR S1735)
Cloture on the measure invoked in Senate by Yea-Nay Vote. 84 - 15. Record Vote Number: 124. (CR S1735) Roll call details
Cloture motion on the measure presented in Senate. (CR S1659)
Considered by Senate. (consideration: CR S1659)
Measure laid before Senate by motion.
Motion to proceed to consideration of measure agreed to in Senate by Voice Vote. (consideration: CR S1623)
Motion to proceed to measure considered in Senate. (CR S1623)
Cloture on the motion to proceed to the measure invoked in Senate by Yea-Nay Vote. 82 - 12. Record Vote Number: 110. (CR S1596) Roll call details
Motion to proceed to measure considered in Senate. (CR S1596)
Motion to proceed to measure considered in Senate. (CR S1521)
Cloture motion on the motion to proceed to the measure presented in Senate. (CR S1488)
Motion to proceed to consideration of measure made in Senate. (CR S1488)
Placed on Senate Legislative Calendar under General Orders. Calendar No. 18.
Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Read twice and referred to the Committee on the Judiciary.
Introduced in Senate
Actions from Congress.gov, newest first.
Administrative law and regulatory procedures · Department of Justice · Drug trafficking and controlled substances · Licensing and registrations · Research administration and funding
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
67 citations; showing the 25 most recently posted.
ASSOCIATION OF AMERICAN MEDICAL COLLEGES · lobbying firm or registrant: ASSOCIATION OF AMERICAN MEDICAL COLLEGES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
$431,446
Spent on own lobbying
…designation of October 1 as National Latino and Latina Physician Day. Issue: Support the designation of October 1 as National Latino and Latina Physician Day. S.331 - HALT Fentanyl Act Issue: Educate Congress on research and schedule I substances. Issue: Support the US Preventive Services Task Force. Issue: Support oversig…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL FRATERNAL ORDER OF POLICE · lobbying firm or registrant: NATIONAL FRATERNAL ORDER OF POLICE
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · amended · posted Sep 29, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$100,000
Spent on own lobbying
…Our Fallen Heroes Act, which would categorize duty-related cancer fatalities as a line of duty death under the Public Safety Officers Benefits (PSOB) program. S. 331 (Cassidy, R-LA) the Halt All Lethal Trafficking of Fentanyl Act, which would permanently place fentanyl-related substances as a class into schedule I of the Co…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL FRATERNAL ORDER OF POLICE · lobbying firm or registrant: NATIONAL FRATERNAL ORDER OF POLICE
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · amended · posted Sep 29, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$100,000
Spent on own lobbying
…Our Fallen Heroes Act, which would categorize duty-related cancer fatalities as a line of duty death under the Public Safety Officers Benefits (PSOB) program. S. 331 (Cassidy, R-LA) the Halt All Lethal Trafficking of Fentanyl Act, which would permanently place fentanyl-related substances as a class into schedule I of the Co…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL FRATERNAL ORDER OF POLICE · lobbying firm or registrant: NATIONAL FRATERNAL ORDER OF POLICE
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · amended · posted Sep 29, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$100,000
Spent on own lobbying
…Our Fallen Heroes Act, which would categorize duty-related cancer fatalities as a line of duty death under the Public Safety Officers Benefits (PSOB) program. S. 331 (Cassidy, R-LA) the Halt All Lethal Trafficking of Fentanyl Act, which would permanently place fentanyl-related substances as a class into schedule I of the Co…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL FRATERNAL ORDER OF POLICE · lobbying firm or registrant: NATIONAL FRATERNAL ORDER OF POLICE
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · amended · posted Sep 29, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$100,000
Spent on own lobbying
…Our Fallen Heroes Act, which would categorize duty-related cancer fatalities as a line of duty death under the Public Safety Officers Benefits (PSOB) program. S. 331 (Cassidy, R-LA) the Halt All Lethal Trafficking of Fentanyl Act, which would permanently place fentanyl-related substances as a class into schedule I of the Co…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL FRATERNAL ORDER OF POLICE · lobbying firm or registrant: NATIONAL FRATERNAL ORDER OF POLICE
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · amended · posted Sep 29, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$100,000
Spent on own lobbying
…Our Fallen Heroes Act, which would categorize duty-related cancer fatalities as a line of duty death under the Public Safety Officers Benefits (PSOB) program. S. 331 (Cassidy, R-LA) the Halt All Lethal Trafficking of Fentanyl Act, which would permanently place fentanyl-related substances as a class into schedule I of the Co…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DUE PROCESS INSTITUTE · lobbying firm or registrant: DUE PROCESS INSTITUTE
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Aug 13, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$15,000
Spent on own lobbying
…ns; supporting increased prosecutorial and policing accountability; supporting clemencies, commutations, and pardons; opposing the HALT Fentanyl Act (H.R. 27 / S. 331); opposing overcriminalization (creation of unnecessary federal criminal laws or regulations with poorly defined terms or weak mens rea protections or those th…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ASSOCIATION OF AMERICAN MEDICAL COLLEGES · lobbying firm or registrant: ASSOCIATION OF AMERICAN MEDICAL COLLEGES
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 17, 2026 · issue area: Health Issues
$821,438
Spent on own lobbying
…designation of October 1 as National Latino and Latina Physician Day. Issue: Support the designation of October 1 as National Latino and Latina Physician Day. S.331 - HALT Fentanyl Act Issue: Educate Congress on research and schedule I substances. Issue: Support the US Preventive Services Task Force. Issue: Support oversig…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
UNIVERSITY OF IOWA · lobbying firm or registrant: UNIVERSITY OF IOWA
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 17, 2026 · issue area: Health Issues
$50,000
Spent on own lobbying
…e Hepatitis C Act of 2025, S. 1941 Concerns with delayed Notice of Funding Opportunity announcements at HHS, and specifically HRSA Implementation concerns with S.331 - HALT Fentanyl Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DUE PROCESS INSTITUTE · lobbying firm or registrant: DUE PROCESS INSTITUTE
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Jun 1, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$15,000
Spent on own lobbying
…ns; supporting increased prosecutorial and policing accountability; supporting clemencies, commutations, and pardons; opposing the HALT Fentanyl Act (H.R. 27 / S. 331); opposing overcriminalization (creation of unnecessary federal criminal laws or regulations with poorly defined terms or weak mens rea protections or those th…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ASSOCIATION OF AMERICAN MEDICAL COLLEGES · lobbying firm or registrant: ASSOCIATION OF AMERICAN MEDICAL COLLEGES
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 16, 2026 · issue area: Health Issues
$577,720
Spent on own lobbying
…igher education to expand or support graduate education for physicians, focusing on institutions in states with the most severe primary care provider shortage. S.331 - HALT Fentanyl Act Issue: Educate Congress on research and schedule I substances. Issue: Support the US Preventive Services Task Force. Issue: Support oversig…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DUE PROCESS INSTITUTE · lobbying firm or registrant: DUE PROCESS INSTITUTE
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Feb 25, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$10,000
Spent on own lobbying
…ns; supporting increased prosecutorial and policing accountability; supporting clemencies, commutations, and pardons; opposing the HALT Fentanyl Act (H.R. 27 / S. 331); opposing overcriminalization (creation of unnecessary federal criminal laws or regulations with poorly defined terms or weak mens rea protections or those th…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PEACE OFFICERS RESEARCH ASSOCIATION OF CALIFORNIA · lobbying firm or registrant: STEPTOE LLP
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$50,000
Paid to lobbying firm
…ct (S. 679, H.R. 2243); Prevent Family Fire Act (H.R. 169); Thin Blue Line Act (S. 83, H.R. 378); Protect and Serve Act (S. 167, H.R. 1551); HALT Fentanyl Act (S. 331, H.R. 27); Marc Fischer Memorial Interdiction of Fentanyl in Postal Mail at Federal Prisons Act / BOP SCAN Mail Act (S. 1295, H.R. 1046); Combating Illicit Xyl…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BRAINFUTURES · lobbying firm or registrant: HOOPER, LUNDY & BOOKMAN, P.C.
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Health Issues
$40,000
Paid to lobbying firm
…or psychedelic drugs and therapies; Issues related to medical adoption of and access to psychedelic drugs and therapies, including reimbursement and workforce; S. 331 - HALT Fentanyl Act, provisions related to research.; H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, fundi…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BRAINFUTURES · lobbying firm or registrant: HOOPER, LUNDY & BOOKMAN, P.C.
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Medical/Disease Research/Clinical Labs
$40,000
Paid to lobbying firm
…or psychedelic drugs and therapies, including reimbursement and workforce; Issues related to medical adoption of and access to psychedelic drugs and therapies; S. 331 - HALT Fentanyl Act, provisions related to research.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ASSOCIATION OF AMERICAN MEDICAL COLLEGES · lobbying firm or registrant: ASSOCIATION OF AMERICAN MEDICAL COLLEGES
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Health Issues
$708,395
Spent on own lobbying
…igher education to expand or support graduate education for physicians, focusing on institutions in states with the most severe primary care provider shortage. S.331 - HALT Fentanyl Act Issue: Educate Congress on research and schedule I substances. Issue: Support the US Preventive Services Task Force. Issue: Support oversig…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ACT FOR AMERICA · lobbying firm or registrant: ACT FOR AMERICA
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Dec 5, 2025 · issue area: Homeland Security
$10,000
Spent on own lobbying
S.3008 - No Shari's Act H.R. 27 and S.331 - HALT Fentanyl Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DUE PROCESS INSTITUTE · lobbying firm or registrant: DUE PROCESS INSTITUTE
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 23, 2025 · issue area: Law Enforcement/Crime/Criminal Justice
$40,000
Spent on own lobbying
…ns; supporting increased prosecutorial and policing accountability; supporting clemencies, commutations, and pardons; opposing the HALT Fentanyl Act (H.R. 27 / S. 331); opposing overcriminalization (creation of unnecessary federal criminal laws or regulations with poorly defined terms or weak mens rea protections or those th…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PEACE OFFICERS RESEARCH ASSOCIATION OF CALIFORNIA · lobbying firm or registrant: STEPTOE LLP
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 20, 2025 · issue area: Law Enforcement/Crime/Criminal Justice
$50,000
Paid to lobbying firm
…ct (S. 679, H.R. 2243); Prevent Family Fire Act (H.R. 169); Thin Blue Line Act (S. 83, H.R. 378); Protect and Serve Act (S. 167, H.R. 1551); HALT Fentanyl Act (S. 331, H.R. 27); Marc Fischer Memorial Interdiction of Fentanyl in Postal Mail at Federal Prisons Act / BOP SCAN Mail Act (S. 1295, H.R. 1046); Combating Illicit Xyl…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ASSOCIATION OF AMERICAN MEDICAL COLLEGES · lobbying firm or registrant: ASSOCIATION OF AMERICAN MEDICAL COLLEGES
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 19, 2025 · issue area: Health Issues
$758,175
Spent on own lobbying
…igher education to expand or support graduate education for physicians, focusing on institutions in states with the most severe primary care provider shortage. S.331 - HALT Fentanyl Act Issue: Educate Congress on research and schedule I substances. Issue: Support the US Preventive Services Task Force. Issue: Support oversig…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BRAINFUTURES · lobbying firm or registrant: HOOPER, LUNDY & BOOKMAN, P.C.
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 19, 2025 · issue area: Health Issues
$40,000
Paid to lobbying firm
…l funding of clinical research trials for psychedelic drugs and therapies; Issues related to medical adoption of and access to psychedelic drugs and therapies; S. 331 - HALT Fentanyl Act, provisions related to research.; H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, fundi…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BRAINFUTURES · lobbying firm or registrant: HOOPER, LUNDY & BOOKMAN, P.C.
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 19, 2025 · issue area: Medical/Disease Research/Clinical Labs
$40,000
Paid to lobbying firm
…l funding of clinical research trials for psychedelic drugs and therapies; Issues related to medical adoption of and access to psychedelic drugs and therapies; S. 331 - HALT Fentanyl Act, provisions related to research.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ACT FOR AMERICA · lobbying firm or registrant: ACT FOR AMERICA
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Sep 16, 2025 · issue area: Government Issues
$10,000
Spent on own lobbying
…ne Big Beautiful Bill Act, sponsor Jodey Arrington (R-TX-19) was a budget reconciliation package signed into law by President Trump on July 17, 2025. H.R. 27 / S. 331 - HALT Fentanyl Act, sponsor: Senator Bill Cassidy (R-LA) H.R.22 - SAVE Act - Chip Roy (R-TX-21)
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DUE PROCESS INSTITUTE · lobbying firm or registrant: DUE PROCESS INSTITUTE
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Aug 21, 2025 · issue area: Law Enforcement/Crime/Criminal Justice
$40,000
Spent on own lobbying
…ns; supporting increased prosecutorial and policing accountability; supporting clemencies, commutations, and pardons; opposing the HALT Fentanyl Act, H.R. 27 / S. 331; opposing overcriminalization (creation of unnecessary federal criminal laws or regulations with poorly defined terms or weak mens rea protections or those tha…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS · lobbying firm or registrant: MASON CONSULTING, LLC
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 23, 2025 · issue area: Health Issues
$24,000
Paid to lobbying firm
…ental health services and violence prevention Introduction of the Future Advancement of Academic Nursing (FAAN) Act H.R. 1, One Big, Beautiful Bill Act H.R. 27/S. 331, Halt All Lethal Trafficking of (HALT) Fentanyl Act H.R. 1715/S. 786, Public Health Funding Restoration Act H.R. 1735/S. 779, Early Action and Responsiveness L…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing